We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

44 hedge funds and large institutions have $7.51M invested in Clearside Biomedical in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 43 → 44 (+1)

0.04% more ownership

Funds ownership: 0.76% → 0.81% (+0.04%)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

7% less capital invested

Capital invested by funds: $8.09M → $7.51M (-$581K)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$460K
2
GCP
GSA Capital Partners
United Kingdom
+$275K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.7K
4
Stifel Financial
Stifel Financial
Missouri
+$13.2K
5
GWP
Gen-Wealth Partners
Michigan
+$8.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$145K
2
Renaissance Technologies
Renaissance Technologies
New York
-$47.9K
3
BCM
Bridgeway Capital Management
Texas
-$41.4K
4
UBS Group
UBS Group
Switzerland
-$24.4K
5
Prudential Financial
Prudential Financial
New Jersey
-$22.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
26
Mariner
Kansas
$15.2K – – –
WA
27
Waverly Advisors
Alabama
$14.7K – – –
OC
28
Oppenheimer & Co
New York
$11.5K – – –
SWA
29
Stratos Wealth Advisors
Ohio
$11.2K – – –
Cambridge Investment Research Advisors
30
Cambridge Investment Research Advisors
Iowa
$8K – – –
RWM
31
Rockwood Wealth Management
Pennsylvania
$8K – – –
GWP
32
Gen-Wealth Partners
Michigan
$8K +$8.28K +667 New
Wells Fargo
33
Wells Fargo
California
$4.8K +$4.96K +400 New
Osaic Holdings
34
Osaic Holdings
Arizona
$2.16K +$1.4K +113 +169%
Bank of America
35
Bank of America
North Carolina
$1.73K +$211 +17 +13%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$1K +$1.15K +93 New
CIBC Private Wealth Group
37
CIBC Private Wealth Group
Georgia
$880 – – –
Raymond James Financial
38
Raymond James Financial
Florida
$799 +$832 +67 New
JP Morgan Chase
39
JP Morgan Chase
New York
$672 -$7.56K -609 -92%
TRCT
40
Tower Research Capital (TRC)
New York
$648 -$3.4K -274 -84%
SS
41
SBI Securities
Japan
$626 +$248 +20 +63%
CFD
42
Creative Financial Designs
Indiana
$80 – – –
AF
43
Allworth Financial
California
$40 +$37 +3 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$2 – – –
Prudential Financial
45
Prudential Financial
New Jersey
– -$22.4K -1,627 Closed
TSS
46
Two Sigma Securities
New York
– -$19.2K -1,394 Closed
Hudson Bay Capital Management
47
Hudson Bay Capital Management
Connecticut
– -$16.9K -1,227 Closed
ARC
48
Advisor Resource Council
Texas
– -$13.8K -1,000 Closed
LFG
49
Larson Financial Group
Missouri
– -$918 -67 Closed
Simplex Trading
50
Simplex Trading
Illinois
– +$99 +8 New
1
2

CLSD Hedge Fund Activity: Q2 2025 in Review

44 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q2 2025, worth a combined $7.51M — down 7.2% from $8.09M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CLSD positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $460K. The largest seller was BlackRock, cutting an estimated $145K.

  • 44 institutional investors held Clearside Biomedical (CLSD) as of Q2 2025, up from 43 in Q1 2025.
  • Funds reported $7.51M of Clearside Biomedical stock for Q2 2025, down 7.2% quarter-over-quarter.
  • 6 funds opened new Clearside Biomedical positions in Q2 2025 and 5 closed out, a net change of +1 holder.
  • The largest Clearside Biomedical buyer in Q2 2025 was Vanguard Group, an estimated $460K added.
  • The largest Clearside Biomedical seller in Q2 2025 was BlackRock, an estimated $145K sold.

Based on aggregated 13F filings for Q2 2025.